Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Open-label Trial of Leukine in Active Crohn's Disease

This study has been terminated.
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company ) Identifier:
First received: September 13, 2005
Last updated: December 2, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)